Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma Genta Incorporated (OTCBB: GNTA) announced the presentation of a progress update from the Company's ongoing Phase 3 trial of Genasense(R) (oblimersen sodium) Injection, Genta's lead oncology product, in patients with advanced melanoma.A...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction INDIANAPOLIS and NEW YORK, Oct.6 /PRNewswire-FirstCall/ -- Eli Lilly and Company and ImClone Systems Inc.
today announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will...
Lilly to Acquire ImClone Systems For Release: Immediately Refer to: Lilly: (317) 276-5795 - Mark E.Taylor or (317) 276-5046 - Angela Sekston ImClone: (908) 243-9945 - Tracy Henrikson or (646) 638-5045 - Rebecca Gregory media@imclone.com in $6.5 Billion Transaction...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction INDIANAPOLIS and NEW YORK, Oct.6 /PRNewswire-FirstCall/ -- Eli Lilly and Company and ImClone Systems Inc.
today announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction INDIANAPOLIS and NEW YORK, Oct.6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and ImClone Systems Inc.
(Nasdaq: IMCL) today announced that the boards of directors of both companies have approved a definitive merger...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction INDIANAPOLIS and NEW YORK, Oct.6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and ImClone Systems Inc.
(Nasdaq: IMCL) today announced that the boards of directors of both companies have approved a definitive merger...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction INDIANAPOLIS and NEW YORK, Oct.6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and ImClone Systems Inc.
(Nasdaq: IMCL) today announced that the boards of directors of both companies have approved a definitive merger...
Pfizer, Boehringer Ingelheims Spiriva Offers No Advantage Over Inhaled Placebo For COPD Ingelheims Spiriva Offers No Advantage Over Inhaled Placebo For COPD cookieGood (navigator.cookieEnabled cookieGood 0) TMC Launches New Web Sites: EXPO East begins in: 11:30 : Columnists: TMCnet TMCnet Columnists Over IP HD Video Internet...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific Development at...
Nutrition Wise: Weight Loss and Lowering Cancer Risk; Mushrooms and Vitamin D; Burger and Sandwich without Che Washington, D.C.- - infoZine - Q: Can people who are already overweight reduce their cancer risk if they lose weight?
A: Most adult cancers develop over a 10 to 20 year period or longer?
Although researchers can't say for sure...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera Readies R & D facilities for Ap3ana, CTI's 'personalized medicine' venture SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera Readies R & D facilities for Ap3ana, CTI's 'personalized medicine' venture SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President...
Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology (BUSINESS WIRE) -- Amgen Inc., (NASDAQ: AMGN) announced it has received a summary of preliminary results from the Cochrane Collaboration's independent meta-analysis of patient-level data from previously conducted, randomized, controlled,...
Q Pharma, Inc. Launches iValidate 2.0 BUSINESS WIRE)--Q Pharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today the official release of their online practitioner validation application, iValidateTM 2.0.This tool assists...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera Readies R & D facilities for Ap3ana, CTI's 'personalized medicine' venture SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera Infants Learn Best from Experience (12 min ago) Speed of Increase in CO2 Emissions by Humans Four as Fast as in Last Decade(20 min ago) 20pct Brit Teachers Demand Revival of Corporal Punishment as Children Become Uncontrollable(31 min ago)...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera Readies R & D facilities for Ap3ana, CTI's 'personalized medicine' venture SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera /PRNewswire-FirstCall via COMTEX/ -- NVS | Quote | Chart | News | PowerRating -- Cell Therapeutics, Inc.(CTI) (Nasdaq: CTIC | Quote | Chart | News | PowerRating) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera Readies R & D facilities for Ap3ana, CTI's 'personalized medicine' venture SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC) announced today that Christina A.
Waters, Ph.D., M.B.A., most...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific...
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera SEATTLE, Oct.3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC) announced today that Christina A.
Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific...
